Summary of Significant Accounting Policies (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Summary of Weighted-Average Number of Common Shares Used to Calculate Basic and Diluted Net Income Loss Per Share

The following table presents the weighted-average number of common shares used to calculate basic and diluted net income (loss) per share:

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Weighted-average number of common shares used in calculating basic net income (loss) per share		35,292,035		34,449,769		35,273,394		34,432,057
Weighted average number of common shares used in calculating diluted net income (loss) per share		36,589,774		34,449,769		35,273,394		34,432,057
Anti-dilutive shares:
Common stock options		7,886,188		7,317,199		9,183,927		7,317,199
Common stock warrants		1,366,141		1,366,141		1,366,141		1,366,141
Potentially dilutive shares excluded from calculation due to antidilutive effect		9,252,329		8,683,340		10,550,068		8,683,340

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	June 30,		December 31,
	2024		2023
Australian research and development tax incentive	$	692	$	2,054
Prepaid clinical development		556		1,008
Prepaid insurance		250		532
Other receivables		407		497
Prepaid other		473		422
Other current assets		317		235
Total prepaid expenses and other current assets	$	2,695	$	4,748